Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Synthesis of Mirror-Image Proteins Reveals Chirality-Dependent Cellular Uptake Mediated by a Cell-Penetrating Peptide.

Journal of the American Chemical Society·2026
Same author

Discovery of ferroptosis-inducing R4VP compounds for targeting aggressive cancers.

Oncogene·2026
Same author

Total Chemical Synthesis of RNF4 by Sequential Native Chemical Ligation: C-To-N Versus N-To-C Strategies.

The Journal of organic chemistry·2026
Same author

SpyTag/SpyCatcher-mediated protein ubiquitination to investigate 20S and 26S proteasomal degradation.

Chemical science·2025
Same author

Direct Cellular Screening of Pd-Mediated Arylation of Cyclic Peptide Binders Targeting Ubiquitin Chains: Toward Modulating NEMO Liquid-Liquid Phase Separation.

Journal of the American Chemical Society·2025
Same author

Chemical approaches to explore ubiquitin-like proteins.

RSC chemical biology·2025

Related Experiment Video

Updated: May 27, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

Fighting hepatitis C virus with peptide nanotubes.

Ashraf Brik1

  • 1Department of Chemistry, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel. abrik@bgu.ac.il

Chemistry & Biology
|November 29, 2011
PubMed
Summary

New peptide nanotubes offer a novel strategy to combat hepatitis C virus (HCV) by blocking its entry into cells. This research presents a promising therapeutic avenue for HCV infection.

Area of Science:

  • Biotechnology
  • Virology
  • Nanomedicine

Background:

  • Hepatitis C virus (HCV) infection poses a significant global health challenge, necessitating novel therapeutic strategies.
  • Existing treatment options for HCV are limited, highlighting the urgent need for alternative approaches with distinct mechanisms of action.

Discussion:

  • Montero and coworkers investigated the potential of peptide nanotubes as an antiviral agent against HCV.
  • The study demonstrates that these nanostructures can effectively inhibit the entry of HCV into host cells.

Key Insights:

  • Peptide nanotubes present a viable method for blocking HCV cell entry.
  • This mechanism offers a new mode of action for developing anti-HCV therapies.

Outlook:

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: May 27, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

  • Further research into peptide nanotube-based therapies could lead to innovative treatments for hepatitis C.
  • This approach holds promise for overcoming drug resistance and improving patient outcomes in HCV management.